在ST段升高心肌梗塞的未来治疗策略
Stephan Windecker1, Jeroen J Bax, Aung Myat
1Department of Cardiology, Bern University Hospital, Bern, Switzerland. stephan.windecker@insel.ch
Lancet (London, England)
|August 20, 2013
概括
对ST段升高心肌梗塞 (STEMI) 的治疗已取得显著进展,包括网络激活,药物和再注射疗法. 目前正在进行的研究正在寻找新的治疗方法,以进一步改善这种常见死亡原因的治疗结果.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 紧急医疗 紧急医疗
背景情况:
- 在过去的50年里,ST段升高心肌梗塞 (STEMI) 的治疗方法有所发展.
- 目前的策略包括网络激活,抗血栓剂和机械再注射.
- 尽管有所改善,但STEMI仍然是致病率和死亡率的重要原因.
研究的目的:
- 审查STEMI管理的演变.
- 突出目前的治疗方法和正在进行的研究.
- 确定进一步改善患者治疗结果的领域.
主要方法:
- 对当代STEMI管理协议的审查.
- 讨论机械反和诊断成像技术的进展.
- 探索针对动脉样硬化和炎症的新型治疗途径.
主要成果:
- 现在,STEMI的管理涉及到一个系统的护理链,包括早期识别和医院前诊断.
- 支架设计和心脏MRI的改进增强了机械再输和心脏病发作大小可视化.
- 新的治疗方法如可生物吸收的血管支架和抗增殖药物正在出现.
结论:
- 在STEMI管理方面取得了实质性的进展,目前正在努力减少延迟和优化治疗.
- 专注于炎症,心脏保护和再生的新治疗策略对未来患者的治疗结果充满希望.
- 持续创新对于进一步降低与STEMI相关的发病率和死亡率至关重要.
相关概念视频
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


